Stock Analysis

3 Stocks That Might Be Trading Below Estimated Fair Value

SHSE:688046
Source: Shutterstock

As global markets grapple with inflation concerns and political uncertainties, U.S. equities have seen a decline, with small-cap stocks underperforming and value stocks showing relative resilience. Amid this choppy market environment, identifying undervalued stocks can offer potential opportunities for investors looking to capitalize on discrepancies between current market prices and estimated fair values.

Top 10 Undervalued Stocks Based On Cash Flows

NameCurrent PriceFair Value (Est)Discount (Est)
Turkcell Iletisim Hizmetleri (IBSE:TCELL)TRY95.20TRY190.0349.9%
Türkiye Sise Ve Cam Fabrikalari (IBSE:SISE)TRY39.18TRY78.3450%
Bank BTPN Syariah (IDX:BTPS)IDR860.00IDR1715.8649.9%
German American Bancorp (NasdaqGS:GABC)US$39.26US$78.0649.7%
GemPharmatech (SHSE:688046)CN¥13.06CN¥25.9849.7%
Shinko Electric Industries (TSE:6967)¥5865.00¥11696.0949.9%
AK Medical Holdings (SEHK:1789)HK$4.28HK$8.5249.8%
TSE (KOSDAQ:A131290)₩43400.00₩86241.9949.7%
Jiangsu Chuanzhiboke Education Technology (SZSE:003032)CN¥9.20CN¥18.4050%
Coeur Mining (NYSE:CDE)US$6.35US$12.6349.7%

Click here to see the full list of 874 stocks from our Undervalued Stocks Based On Cash Flows screener.

Let's take a closer look at a couple of our picks from the screened companies.

Zhuzhou Times New Material Technology (SHSE:600458)

Overview: Zhuzhou Times New Material Technology Co., Ltd. operates in the field of advanced materials and components, with a market capitalization of approximately CN¥10.42 billion.

Operations: Zhuzhou Times New Material Technology Co., Ltd. generates its revenue from various segments, though specific segment details are not provided in the available information.

Estimated Discount To Fair Value: 13.2%

Zhuzhou Times New Material Technology is trading at CN¥12.64, below its estimated fair value of CN¥14.56, suggesting it may be undervalued based on cash flows. Despite a low return on equity forecast of 12.5% in three years, earnings are expected to grow significantly at 33.8% annually, outpacing the Chinese market's growth rate of 24.8%. Recent earnings show modest revenue and net income increases year-over-year, indicating potential for future growth.

SHSE:600458 Discounted Cash Flow as at Jan 2025
SHSE:600458 Discounted Cash Flow as at Jan 2025

GemPharmatech (SHSE:688046)

Overview: GemPharmatech Co., Ltd. is a contract research organization that offers genetically engineered mouse models and preclinical research services globally, with a market cap of CN¥5.33 billion.

Operations: GemPharmatech Co., Ltd.'s revenue primarily comes from providing genetically engineered mouse models and preclinical research services to the global scientific community.

Estimated Discount To Fair Value: 49.7%

GemPharmatech, trading at CN¥13.06, is significantly undervalued compared to its estimated fair value of CN¥25.98. The company forecasts robust revenue growth of 22.1% annually and earnings growth of 27.4%, both surpassing market averages. Despite a low future return on equity forecasted at 9.8%, recent strategic initiatives like share buybacks and innovative product developments through NeoMab enhance its potential for long-term value creation amidst current financial challenges.

SHSE:688046 Discounted Cash Flow as at Jan 2025
SHSE:688046 Discounted Cash Flow as at Jan 2025

Peric Special Gases (SHSE:688146)

Overview: Peric Special Gases Co., Ltd. focuses on the R&D, production, and sale of electronic special gases and trifluoromethanesulfonic acid series products in China, with a market cap of CN¥14.85 billion.

Operations: The company's revenue segments include electronic special gases and trifluoromethanesulfonic acid series products.

Estimated Discount To Fair Value: 21.6%

Peric Special Gases, trading at CN¥28.05, is undervalued with an estimated fair value of CN¥35.79. The company anticipates revenue growth of 22.1% annually, outpacing the market average of 13.3%. Although earnings are expected to grow at 24.13% per year, slightly below the market rate, the stock's valuation remains attractive despite recent declines in net income and limited dividend coverage by free cash flows.

SHSE:688146 Discounted Cash Flow as at Jan 2025
SHSE:688146 Discounted Cash Flow as at Jan 2025

Summing It All Up

  • Click here to access our complete index of 874 Undervalued Stocks Based On Cash Flows.
  • Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
  • Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Ready For A Different Approach?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com